26.1 C
New York
Monday, June 8, 2026

Tag: association

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney diseaseZHUBEI CITY, Taiwan and RALEIGH, N.C.,...

Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes

Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More Advanced Approach to Early IdentificationNEW ORLEANS, June 5,...

Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism...

STAMFORD, Conn., June 05, 2026 (GLOBE NEWSWIRE) -- Oban BioPharma today announced that preclinical data for OBT-676, a lead small-molecule candidate for the treatment of obesity and type 2 diabetes, has been selected for a late-breaking presentation at the upcoming American Diabetes Association (ADA) 86th Scientific Sessions being held from June 5th-8th in New Orleans, LA. The study characterizes OBT-676 as a new molecular entity that achieves potent full agonism at the amylin and calcitonin receptors (DACRA) while simultaneously delivering partial agonism across the GLP-1, GIP, and glucagon (Triple-G) pathways. OBT-676 demonstrated significant reduction in food intake and adipose-selective weight loss in the industry-standard rat diet-induced obesity (DIO) model.

Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026

A phase 2 study of investigational once-weekly subcutaneous zenagamtide showed statistically significant reductions in blood sugar in adults with type 2 diabetes compared to...

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin UseNEW ORLEANS, June 5, 2026 /PRNewswire/ -- A...

MICHAEL FEINSTEIN CELEBRATES PRIDE MONTH WITH THE RELEASE OF NEW ANTHEM “GAYMEN” LEAD VOCALS BY motherfather, FEATURING A SPECIAL APPEARANCE BY LIZA MINNELLI

Michael Feinstein and Bobby Daye Unveil FeinDaye, a New Creative Venture Bridging Music, Entertainment and Live ExperiencesLOS ANGELES, June 5, 2026 /PRNewswire/ -- Acclaimed...

Greenberg Traurig Expands Health Care & FDA Capabilities in California with Addition of Deborah J. Rotenberg and Team

SACRAMENTO, Calif., June 5, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP continues the growth of its Health Care & FDA Practice with the...

Centurion Acquisition Corp. Announces Postponement of Shareholders’ Meeting to Friday, June 12, 2026, and Extension of Redemption Request Deadline

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Centurion Acquisition Corp., a Cayman Islands exempted company, (“Centurion” or the “Company”) (Nasdaq: ALF) today announced that it intends to postpone its previously announced Extraordinary General Meeting of shareholders (the “Meeting”) from June 9, 2026, at 11:00 a.m. Eastern Time, to June 12, 2026 at 11:00 a.m. Eastern Time to allow Centurion additional time to engage with shareholders.

Victoire : un projet de loi vise à encadrer la vente des boissons énergisantes caféinées aux jeunes de moins de 16 ans

MONTRÉAL, 05 juin 2026 (GLOBE NEWSWIRE) -- Cœur + AVC et le Collectif Vital applaudissent le dépôt du projet de loi 9, Loi visant à prévenir les effets nocifs de la boisson énergisante sur la santé des jeunes, ou Zachary-Miron, qui vise à interdire la vente de boissons énergisantes caféinées aux jeunes de moins de 16 ans. Cette mesure témoigne de l’engagement et du leadership de la province envers la protection de la santé des jeunes.

Top Two Spots in American Banker’s 50 Top Innovators in Finance Awarded to CEOs of Vantage Bank and Custodia, Hazel Network’s Co-Founders

Vantage Bank CEO Jeff Sinnott and Custodia CEO Caitlin Long secure the #1 and #2 spots in American Banker's inaugural "The Most Innovative People...

St. Joseph’s Children’s Hospital Cancer Survivor Advocates for Children’s Health Care on Capitol Hill

TAMPA, Fla., June 5, 2026 /PRNewswire/ -- This week, 7-year-old Mikey Hartnett and his parents joined leaders from BayCare and St. Joseph's Children's Hospital...

“Premium Pet Supplies Expo 2026” Officially Opens

Exotic Pets Steal the Spotlight with Debut Reptilia Carnival and Live Insect Exhibition Featuring Over 50 SpeciesHONG KONG, June 5, 2026 /PRNewswire/ -- Organized...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAssociation